查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986352

美國化學指示劑市場規模、佔有率和趨勢分析報告：按產品、方法、應用和細分市場分類（2026-2033 年）

U.S. Chemical Indicators Market Size, Share & Trends Analysis Report By Product, By Method, By End-use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

美國化學指示劑市場概況

據估計，2025年美國化學指示劑市值為1.5643億美元，預計2033年將達到2.2273億美元。

預計從 2026 年到 2033 年，該市場將以 4.59% 的複合年成長率成長。推動該市場成長的因素是醫療機構嚴格的消毒法規和合規要求。

外科手術數量的增加以及門診診所和牙科診所數量的成長，推動了對常規消毒監測的需求。人們對感染預防和病人安全的日益關注，進一步促進了化學指示劑的持續使用。此外，先進消毒技術的應用也催生了對專用指示劑產品的需求。

隨著醫療機構加強滅菌監測以減少醫院感染，人們對感染預防意識的提高持續推動美國化學指示劑市場的發展。由於更加重視病人安全和法規遵從性，醫院、檢查室和手術中心現在都常規使用化學指示劑檢驗滅菌流程。例如，2025年9月，《今日感染控制》（Infection Control Today）雜誌強調了醫療設備無菌在病人安全中的關鍵作用，指出蒸氣滅菌是應用最廣泛的方法，並強調了化學指示劑在檢驗流程有效性方面的重要性。該報導還引用了ISO 11140-1標準，比較了4型和5型指示劑，並概述了它們的性能特徵以及在確保符合規範的滅菌操作中的作用。

根據 ISO 11140-1 標準，4 型化學指示劑旨在對兩個或多個關鍵滅菌製程變數做出反應。相較之下，5 型化學指示劑對所有關鍵變數均有反應，其配方旨在更真實地模擬生物指示劑 (BI) 的性能。對於濕熱滅菌，這些變數通常包括在飽和蒸氣中的暴露時間和溫度（例如，132 度C下 4 分鐘）。該標準還規定了 4 型和 5 型指示劑所需的性能標準和合格/不合格標準。

根據美國疾病管制與預防中心 (CDC) 2025 年 11 月的建議，所有無菌包裝應包含化學指示劑，以確認物品已在適當的滅菌條件下進行滅菌。 CDC 也建議將化學指示劑與機械和生物監測技術結合使用，以提高滅菌的可靠性並支持有效的感染預防通訊協定。因此，人們對感染預防意識的提高正在推動醫療保健及相關領域對化學指示劑的應用。對滅菌驗證和病人安全的日益重視也促進了這些監測產品的常規使用。這種對合規性和品質保證的持續關注，將繼續推動化學指示劑市場的穩定成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國化學指示劑市場的變數、趨勢和範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 美國化學指示劑市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章：美國化學指示劑市場：產品估算與趨勢分析

  • 美國化學指示劑市場：產品波動分析
  • 美國化學指示劑市場規模及趨勢分析（依產品分類，2021-2033 年）
  • 條
  • 指示帶
  • 卡片
  • 其他

第5章：美國化學指示劑市場：依方法論進行的估算與趨勢分析

  • 美國化學指示劑市場：波動分析方法
  • 美國化學指示劑市場規模及趨勢分析（依方法論分類，2021-2033 年）
  • 蒸氣滅菌
  • 環氧乙烷滅菌
  • 過氧化氫滅菌
  • 其他

第6章：美國化學指示劑市場：依最終用途分類的估算與趨勢分析

  • 美國化學指示劑市場：依最終用途分類的波動分析
  • 美國化學指示劑市場規模及應用趨勢分析（2021年至2033年）
  • 醫院和診所
  • 生物製藥/生技公司
  • 門診手術中心
  • 研究機構和學術機構
  • 其他用途

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商情況
    • Key company market share analysis, 2025
    • Propper Manufacturing Co.
    • STERIS
    • ASP
    • Solventum
    • Getinge
    • Tuttnauer
    • Andersen Sterilizers
    • Mesa Laboratories, Inc.
    • Hu-Friedy Mfg. Co.
    • True Indicating
Product Code: GVR-4-68040-860-1

U.S. Chemical Indicators Market Summary

The U.S. chemical indicators market size was estimated at USD 156.43 million in 2025 and is projected to reach USD 222.73 million by 2033, growing at a CAGR of 4.59% from 2026 to 2033. The market is driven by stringent sterilization regulations and compliance requirements across healthcare facilities.

Rising surgical procedure volumes and the growing number of outpatient and dental centers increase the demand for routine sterilization monitoring. Increased focus on infection prevention and patient safety further supports consistent use of chemical indicators. In addition, the adoption of advanced sterilization technologies is creating demand for specialized indicator products.

The increasing awareness of infection prevention continues to drive the U.S. market for chemical indicators, as healthcare facilities strengthen sterilization monitoring to reduce hospital-acquired infections. Greater emphasis on patient safety and regulatory compliance has led to routine validation of sterilization cycles using chemical indicators across hospitals, laboratories, and surgical centers. For instance, in September 2025, Infection Control Today underscored the critical role of medical device sterility in patient safety, highlighting steam sterilization as the most widely used method and emphasizing the importance of chemical indicators in verifying process effectiveness. The article also referenced ISO 11140-1 standards and compared Type 4 and Type 5 indicators, outlining their performance characteristics and role in ensuring compliant sterilization practices.

According to ISO 11140-1, Type 4 chemical indicators are designed to react to two or more critical sterilization process variables. In comparison, Type 5 chemical indicators respond to all critical variables and are formulated to more closely mimic the performance of a biological indicator (BI). For moist heat sterilization, these variables generally include exposure time and temperature in saturated steam, such as 132°C for 4 minutes. The standard also specifies the required performance criteria and pass/fail conditions for both Type 4 and Type 5 indicators.

According to the U.S. Centers for Disease Control and Prevention in November 2025, chemical indicators are recommended inside every sterilization package to verify that items have been exposed to appropriate sterilizing conditions. The CDC further recommends using chemical indicators in combination with mechanical and biological monitoring methods to enhance assurance of sterilization and support effective infection prevention protocols. As a result, increasing awareness of infection prevention is driving wider adoption of chemical indicators across healthcare and allied sectors. Greater emphasis on sterilization validation and patient safety is reinforcing the routine use of these monitoring products. This sustained focus on compliance and quality assurance continues to contribute to steady growth in the chemical indicators market.

U.S. Chemical Indicators Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. chemical indicators market report based on product, method, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Strips
  • Indicator Tapes
  • Cards
  • Others
  • Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Steam Sterilization
  • Ethylene Oxide Sterilization
  • Hydrogen Peroxide Sterilization
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Biopharma/Biotech Companies
  • Ambulatory Surgery Centers
  • Research and Academic Institutes
  • Other End Use

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Method
    • 1.1.3. End Use
    • 1.1.4. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Price Analysis (Model 1)
    • 1.6.2. Approach 1: Commodity Flow Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Chemical Indicators Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising surgical procedure volume
      • 3.2.1.2. Growing focus on infection prevention
      • 3.2.1.3. Increase in surgical and diagnostic procedures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced indicators
      • 3.2.2.2. Preference for biological indicators
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing focus on infection prevention
      • 3.2.3.2. Expansion into non-healthcare sectors
      • 3.2.3.3. Increasing number of clinical trials
      • 3.2.3.4. Technological advancements
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Competition from alternative technologies
      • 3.2.4.2. Variable regulatory requirements
  • 3.3. U.S. Chemical Indicators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Chemical Indicators Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Chemical Indicators Market Product Movement Analysis
  • 4.3. U.S. Chemical Indicators Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
  • 4.4. Strips
    • 4.4.1. Strips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Indicator Tapes
    • 4.5.1. Indicator tapes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Cards
    • 4.6.1. Cards market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Chemical Indicators Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Chemical Indicators Market Method Movement Analysis
  • 5.3. U.S. Chemical Indicators Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
  • 5.4. Steam Sterilization
    • 5.4.1. Steam sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ethylene Oxide Sterilization
    • 5.5.1. Ethylene oxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Hydrogen Peroxide Sterilization
    • 5.6.1. Hydrogen peroxide sterilization market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Estimates and Forecasts for 2021 to 2033, (USD Million)

Chapter 6. U.S. Chemical Indicators Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Chemical Indicators Market End Use Movement Analysis
  • 6.3. U.S. Chemical Indicators Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 6.4. Hospitals and Clinics
    • 6.4.1. Hospitals and clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharma/Biotech Companies
    • 6.5.1. Biopharma/biotech companies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ambulatory Surgery Centers
    • 6.6.1. Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Research and Academic Institutes
    • 6.7.1. Research and academic institutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Other End-Use
    • 6.8.1. Other end-use market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2025
    • 7.3.2. Propper Manufacturing Co.
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Usage benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. STERIS
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Usage benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. ASP
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Usage benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Solventum
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Usage benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Getinge
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Usage benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Tuttnauer
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Usage benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Andersen Sterilizers
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Usage benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Mesa Laboratories, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Usage benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Hu-Friedy Mfg. Co.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Usage benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. True Indicating
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Usage benchmarking
      • 7.3.11.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. chemical indicators market, by country, 2021 - 2033 (USD Million)
  • Table 4. U.S. chemical indicators market, by product, 2021 - 2033 (USD Million)
  • Table 5. U.S. chemical indicators market, by method, 2021 - 2033 (USD Million)
  • Table 6. U.S. chemical indicators market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Chemical Indicators Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 U.S. Chemical Indicators market: Product movement analysis
  • Fig. 14 Strips market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 15 Indicator tapes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 16 Cards market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 17 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 U.S. Chemical Indicators Market: Method Movement Analysis
  • Fig. 19 Steam sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Ethylene oxide sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Hydrogen peroxide sterilization market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Dental implant market: End Use Movement Analysis
  • Fig. 24 Hospitals and clinics market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Biopharma/biotech companies market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Ambulatory surgery centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Research and academic institutes market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Other end-use market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)